MCRB Seres Therapeutics, Inc.
$1.86▼ -6.06%
Healthcare
Other
Volume 39.5K
Avg Volume (10D) 53.6K
Key Metrics & Fundamentals
Market Cap
$18.68M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.80 - 29.98
% vs 50 MA
-48.34%
% vs 200 MA
-73.19%
RSI-14
16.6
MACD Histogram
+0.0100
Beta (1Y vs SPY)
1.40
Free Cash Flow
-$22.39M
Gross Rev
$736,000
Gross Profit
$736,000
EBITDA
-$33.99M
COGS
$0
Operating Exp
$16.20M
Operating Income
-$15.47M
EBIT
-$15.47M
Pretax Income
$4.58M
Net Income
$4.58M
EPS (Diluted)
0.47
Price & Volume History
Loading chart…
Recent News
Seres Therapeutics to Present Preclinical Data for SER-428, an Investigational Live Biotherapeutic Designed to Reduce Risk of Bloodstream Infections in Critically Ill Patients, at IDWeek 2026
GlobeNewswire · Oct 15, 2026 7:00 AM ET
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Sep 8, 2026 6:00 PM ET
Microbiome Therapeutics Market Report 2026-2035 Featuring Profiles of Ferring Pharmaceuticals, Infant Bacterial Therapeutics, MaaT Pharma, Mikrobiomik, Seres Therapeutics, Vedanta Biosciences
GlobeNewswire · Sep 7, 2026 4:27 AM ET
Seres Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 1, 2026 7:00 AM ET
Seres Therapeutics Files $300 Million Mixed Shelf
MT Newswires · Aug 13, 2026 5:25 PM ET
Seres Therapeutics: Q2 Earnings Snapshot
Associated Press · Aug 5, 2026 7:12 AM ET
Seres Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates, Including Further Action to Reduce Ongoing Facilities Costs
GlobeNewswire · Aug 5, 2026 7:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See MCRB's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.